MicroRNA 7152 (MIR7152)

MicroRNA 7152 (MIR7152) is a predicted human microRNA (short non-coding RNA, typically about 20–24 nucleotides) involved in the post-transcriptional regulation of gene expression[2][5]. Like other miRNAs, MIR7152 is processed from a stem-loop precursor and incorporated into the RNA-induced silencing complex (RISC), allowing it to recognize and downregulate target mRNAs by inhibiting their translation or promoting mRNA degradation[2][5]. There is currently no published evidence for specific biological functions, disease associations, or drug interactions for MIR7152. It is catalogued in sequence databases (HGNC: 50257; NCBI Gene: 102465689; Ensembl: ENSG00000274824), but has not been linked to known clinical relevance or therapeutically actionable pathways[2][5]. Key points for data structuring: - This is a microRNA gene (not a protein, receptor, enzyme, transporter, etc.), classified as a non-coding RNA[2][5]. - There is no evidence that it is a therapeutic target or that it plays a role in disease, drug interaction, or as a biomarker[2][5]. - The target name/abbreviation and aliases are valid, but there is scarce functional or clinical data. Special notes: - This query may represent a mistaken or “empty” therapeutic target: while the microRNA exists, no research currently links it to functional, pathological, or pharmacological relevance. As of now, it is an uncharacterized or computationally annotated entry lacking experimental data. - If you intended a different miRNA (such as miR-152, which is well-studied in cancer) refer to that specific entry instead[3]. Summary: MIR7152 is a human microRNA gene with no known therapeutic or disease role and insufficient information to consider it a validated biomedical target[2][5].

Other names

hsa-mir-7152microRNA mir-7152MIR7152